Our results revealed that α-hederin acted as a new agonist of the Mst1-mediated Hippo signaling pathway and played an inhibitory role in hepatocellular carcinoma (HCC) growth through inhibiting YAP activity. The gene discussed is MST1; the disease is hepatocellular carcinoma.